About: Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 14 May 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en mayu de 2019 (ast) scientific article published on 14 May 2019 (en) наукова стаття, опублікована 14 травня 2019 (uk)
publication date	wds:Q92023463-31E03FFE-8DCB-4AFB-8578-BBA7F38E2A6A
publication date	2019-05-14 00:00:00Z (xsd:dateTime)
cites work	wds:Q92023463-4873845D-2D04-4ECA-9BAC-ADF3476C8D8D wds:Q92023463-552E5830-181E-4FDC-AD7A-C99201AC61D2 wds:Q92023463-6A226069-16C7-439D-BDE4-CB0F3AD5079A wds:Q92023463-85A7AA36-0F24-4873-A234-FB6752DBCF6E wds:Q92023463-B35DC814-8F2B-41EC-8214-998D0D6700E3 wds:Q92023463-C7AFBB81-FB34-446D-8C7A-7DC805682204 wds:Q92023463-D6B530AF-3FF9-43FB-B6A4-F31729C0FC94 wds:Q92023463-D8113774-2AC6-4D5F-A0A5-AE32456C77B4 wds:Q92023463-DBC2DF1C-89D9-45E6-BD3B-33BCBFD000DC wds:Q92023463-E19C4FCB-0D7B-49C4-BFBC-5A0F67585FB8 wds:Q92023463-EB06D55B-4DAF-43D3-9BFD-ED1A5372AE9B wds:Q92023463-FE08A692-4722-40B8-AC69-DB26B0C40F3F
cites work	Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation Population pharmacokinetic study of a test dose oral busulfan in Japanese adult patients undergoing hematopoietic stem cell transplantation Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100- Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoi Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule An evaluation of busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation
author name string	wds:Q92023463-1A518154-9292-4429-869F-101087B54E90 wds:Q92023463-295D1072-9753-49F7-BA06-2FB44CE06E05 wds:Q92023463-58C00611-79C7-4A31-9A8C-A4CB590FC99A wds:Q92023463-61A4081A-FAD4-4093-81E4-5A21EA3E833A wds:Q92023463-63377E58-D8F0-44D0-AF62-545A7833C141 wds:Q92023463-CCF727A9-E30F-494F-9A98-78F15A8F0C65
author name string	Nelson Hamerschlak Juliana Folloni Fernandes Borje S Andersson Fabio Rodrigues Kerbauy José Salvador Rodrigues Oliveira Fabio Pires Souza Santos
rdfs:label	Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study (en) Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study (nl)
skos:prefLabel	Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study (en) Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study (nl)
name	Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study (en) Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study (nl)
author	wds:Q92023463-3E5176F5-B216-40C4-A126-DC32247322C3 wds:Q92023463-60A0D7DF-DA9C-499E-AD09-25EABCA3AD07 wds:Q92023463-DF11FD25-006A-4B6D-AB30-EA5F9CCC8B40
author	Adriana Seber Marcos de Lima Iracema Esteves
title	wds:Q92023463-6158FD40-EBE3-48A7-B20A-ECB667D69389
title	Pharmacokinetics analysis results are similar for oral compared to intravenous busulfan in patients undergoing hematopoietic stem cell transplantation, except for the earlier onset of mucositis. A controlled clinical study (en)
page(s)	wds:Q92023463-D0FC8D71-F260-486F-BA9C-48769E877552
page(s)	1799-1804
instance of	wds:Q92023463-94483C0B-9D51-42A8-9536-FA7DBD382C37
instance of	scholarly article
main subject	wds:Q92023463-FDF99D44-268F-414F-AD2E-DB0E4917EAF3
main subject	stem cell transplantation
PubMed ID	wds:Q92023463-0BD3A268-ECDC-44B4-AC05-FF512B3DD8D8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31089278
PubMed ID	31089278
published in	wds:Q92023463-2BD61508-0692-4723-B9F0-688AFB5FA11F
published in	Bone Marrow Transplantation
issue	wds:Q92023463-66EEF89E-245D-4358-A997-BA8B7D8BC401
volume	wds:Q92023463-5CD4D3E1-6B0C-4690-A7DB-859C7D087837
issue	11
volume	54
DOI	wds:Q92023463-2C8034F3-5D0B-4A31-9180-339D02334711
DOI	http://dx.doi.org/10.1038/S41409-019-0521-5
DOI	10.1038/S41409-019-0521-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q92023463
is cites work of	Targeted-dose of busulfan: higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol.min. A historically-controlled clinical trial
is cites work of	wds:Q98306625-B1FB5C12-1F56-49E2-9144-640D5E036670

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software